Linda Stertman

1.4k total citations
17 papers, 563 citations indexed

About

Linda Stertman is a scholar working on Immunology, Infectious Diseases and Pharmaceutical Science. According to data from OpenAlex, Linda Stertman has authored 17 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 6 papers in Infectious Diseases and 3 papers in Pharmaceutical Science. Recurrent topics in Linda Stertman's work include Immunotherapy and Immune Responses (7 papers), Immune Response and Inflammation (6 papers) and Immune Cell Function and Interaction (3 papers). Linda Stertman is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Immune Response and Inflammation (6 papers) and Immune Cell Function and Interaction (3 papers). Linda Stertman collaborates with scholars based in Sweden, Germany and United States. Linda Stertman's co-authors include Sofia Magnusson, Ingvar Sjöholm, Karin Lövgren Bengtsson, Karin H. Karlsson, Jenny M. Reimer, Karin Lövgren‐Bengtsson, Erik Lundgren, Gregory M. Glenn, Gale Smith and Rory D. de Vries and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Linda Stertman

16 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda Stertman Sweden 12 248 246 159 105 77 17 563
Rafaela Giemza United Kingdom 8 216 0.9× 242 1.0× 87 0.5× 161 1.5× 12 0.2× 9 521
Birgit Thierry-Carstensen Denmark 10 317 1.3× 299 1.2× 108 0.7× 284 2.7× 22 0.3× 15 655
McGhee United States 10 87 0.4× 233 0.9× 103 0.6× 114 1.1× 80 1.0× 18 544
Busen Wang China 7 256 1.0× 57 0.2× 85 0.5× 95 0.9× 39 0.5× 18 414
Hazel Poyntz United Kingdom 12 423 1.7× 409 1.7× 231 1.5× 379 3.6× 33 0.4× 14 833
Svein Rune Andersen Norway 18 179 0.7× 253 1.0× 161 1.0× 298 2.8× 42 0.5× 28 785
Masanori Isaka Japan 18 380 1.5× 237 1.0× 151 0.9× 204 1.9× 299 3.9× 48 826
Wouter ter Veer Netherlands 12 111 0.4× 254 1.0× 140 0.9× 303 2.9× 21 0.3× 13 529
Jason A. Regules United States 11 187 0.8× 118 0.5× 148 0.9× 98 0.9× 238 3.1× 26 495
Youri Lee United States 19 333 1.3× 287 1.2× 135 0.8× 475 4.5× 13 0.2× 47 820

Countries citing papers authored by Linda Stertman

Since Specialization
Citations

This map shows the geographic impact of Linda Stertman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Stertman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Stertman more than expected).

Fields of papers citing papers by Linda Stertman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Stertman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Stertman. The network helps show where Linda Stertman may publish in the future.

Co-authorship network of co-authors of Linda Stertman

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Stertman. A scholar is included among the top collaborators of Linda Stertman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Stertman. Linda Stertman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Carow, Berit, Jens Eriksson, Karin Lövgren Bengtsson, et al.. (2025). Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through induction of lysosomal membrane permeabilization. npj Vaccines. 10(1). 184–184.
2.
Stertman, Linda, Anna-Karin E. Palm, Berit Carow, et al.. (2023). The Matrix-M™ adjuvant: A critical component of vaccines for the 21 st century. Human Vaccines & Immunotherapeutics. 19(1). 2189885–2189885. 59 indexed citations
3.
Carnrot, Cecilia, Berit Carow, Anna-Karin E. Palm, et al.. (2023). Biodistribution of the saponin-based adjuvant Matrix-M™ following intramuscular injection in mice. SHILAP Revista de lepidopterología. 3. 1279710–1279710. 6 indexed citations
4.
Magnusson, Sofia, Arwen F. Altenburg, Karin Lövgren Bengtsson, et al.. (2018). Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice. Immunologic Research. 66(2). 224–233. 57 indexed citations
5.
Altenburg, Arwen F., Sofia Magnusson, Fred T. Bosman, et al.. (2017). Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice. Clinical & Experimental Immunology. 190(1). 19–28. 7 indexed citations
6.
Bengtsson, Karin Lövgren, Haifeng Song, Linda Stertman, et al.. (2016). Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice. Vaccine. 34(16). 1927–1935. 94 indexed citations
7.
Verstrepen, Babs E., Herman Oostermeijer, Zahra Fagrouch, et al.. (2014). Vaccine-Induced Protection of Rhesus Macaques against Plasma Viremia after Intradermal Infection with a European Lineage 1 Strain of West Nile Virus. PLoS ONE. 9(11). e112568–e112568. 13 indexed citations
8.
Magnusson, Sofia, Karin H. Karlsson, Jenny M. Reimer, et al.. (2014). Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice. Vaccine. 32(7). 800–808. 28 indexed citations
9.
10.
Sundling, Christopher, Mats Spångberg, Karin Lövgren Bengtsson, et al.. (2012). Immunization of Macaques With Soluble HIV Type 1 and Influenza Virus Envelope Glycoproteins Results in a Similarly Rapid Contraction of Peripheral B-Cell Responses After Boosting. The Journal of Infectious Diseases. 207(3). 426–431. 24 indexed citations
11.
Reimer, Jenny M., et al.. (2012). Matrix-M™ Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen. PLoS ONE. 7(7). e41451–e41451. 94 indexed citations
12.
Keita, Åsa V., et al.. (2006). Effects of chronic stress on the immune response to oral human serum albumin-conjugated starch microparticles in rats. Journal of Neuroimmunology. 183(1-2). 33–42. 4 indexed citations
13.
Stertman, Linda, et al.. (2006). Use of an oral diphtheria vaccine in human. Vaccine. 24(33-34). 5928–5930. 12 indexed citations
14.
Stertman, Linda, Erik Lundgren, & Ingvar Sjöholm. (2006). Starch microparticles as a vaccine adjuvant: Only uptake in Peyer's patches decides the profile of the immune response. Vaccine. 24(17). 3661–3668. 34 indexed citations
15.
Stertman, Linda, et al.. (2005). Starch microparticles as vaccine adjuvant. Expert Opinion on Drug Delivery. 2(5). 807–828. 27 indexed citations
16.
Stertman, Linda, et al.. (2004). Starch Microparticles as Oral Vaccine Adjuvant: Antigen-dependent Uptake in Mouse Intestinal Mucosa. Journal of drug targeting. 12(5). 289–296. 11 indexed citations
17.
Stertman, Linda, et al.. (2004). Starch microparticles as an adjuvant in immunisation: effect of route of administration on the immune response in mice. Vaccine. 22(21-22). 2863–2872. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rafaela Giemza Breakdown of academic impact, for papers by Birgit Thierry-Carstensen Breakdown of academic impact, for papers by McGhee Breakdown of academic impact, for papers by Busen Wang Breakdown of academic impact, for papers by Hazel Poyntz Breakdown of academic impact, for papers by Svein Rune Andersen Breakdown of academic impact, for papers by Masanori Isaka Breakdown of academic impact, for papers by Wouter ter Veer Breakdown of academic impact, for papers by Jason A. Regules Breakdown of academic impact, for papers by Youri Lee
Rankless by CCL
2026